Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical

    NEXT STORY
    Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy
    PREV STORY
    Global Syringes and Cannulas Market is Expected to Reach USD 2.23 Billion by 2025 : Fior Markets
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curetis Publishes Interim Report for the First Half-Year 2018

    Curetis Publishes Interim Report for the First Half-Year 2018 Amsterdam, the Netherlands, San Diego, ...

    author_avatar
    NASDAQ Market News

    Zafgen to Present at the Leerink Partners 6th Annual Global Healthcare Conference

    BOSTON, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated ...

    author_avatar
    NASDAQ Market News

    Reata Announces That Kyowa Hakko Kirin Initiated Ayame, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Diabetic Kidney Disease

    IRVING, Texas, June 04, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage ...

    author_avatar
    NASDAQ Market News